Search research articles
Contact Us
Filters
Showing results (61-70 of 67) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 67 results.
Healthcare (Basel, Switzerland)
|
May 14, 2025
Communication and Therapy Planning for Patients of Reproductive Age Under Immunomodulatory Treatments for Psoriasis or Psoriatic Arthritis-Survey of the German National Psoriasis Registry PsoBest
Brigitte Stephan, Christina Sorbe, Birgit-Christiane Zyriax, et al.
JIMD Reports
|
March 18, 2016
Living with Intoxication-Type Inborn Errors of Metabolism: A Qualitative Analysis of Interviews with Paediatric Patients and Their Parents
Nina A Zeltner, Markus A Landolt, Matthias R Baumgartner, et al.
Child: Care, Health and Development
|
September 18, 2018
Health-related quality of life experiences in children and adolescents born with esophageal atresia: A Swedish-German focus group study
Stefanie Witt, Michaela Dellenmark-Blom, Sofie Flieder, et al.
BMJ Open
|
February 15, 2023
Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study)
Matthias Augustin, Rachel Sommer, Esteban Daudén, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
May 17, 2019
Cross-cultural selection and validation of instruments to assess patient-reported outcomes in children and adolescents with achondroplasia
Janika Bloemeke, Rachel Sommer, Stefanie Witt, et al.
Psoriasis (Auckland, N.Z.)
|
July 3, 2025
Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive Study
Ulrich Mrowietz, Rachel Sommer, Sascha Gerdes, et al.
Psoriasis (Auckland, N.Z.)
|
May 18, 2026
Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE Study
Ulrich Mrowietz, Rachel Sommer, Ziad Reguiai, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 67) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 67 results.
Healthcare (Basel, Switzerland)
|
May 14, 2025
Communication and Therapy Planning for Patients of Reproductive Age Under Immunomodulatory Treatments for Psoriasis or Psoriatic Arthritis-Survey of the German National Psoriasis Registry PsoBest
Brigitte Stephan, Christina Sorbe, Birgit-Christiane Zyriax, et al.
JIMD Reports
|
March 18, 2016
Living with Intoxication-Type Inborn Errors of Metabolism: A Qualitative Analysis of Interviews with Paediatric Patients and Their Parents
Nina A Zeltner, Markus A Landolt, Matthias R Baumgartner, et al.
Child: Care, Health and Development
|
September 18, 2018
Health-related quality of life experiences in children and adolescents born with esophageal atresia: A Swedish-German focus group study
Stefanie Witt, Michaela Dellenmark-Blom, Sofie Flieder, et al.
BMJ Open
|
February 15, 2023
Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study)
Matthias Augustin, Rachel Sommer, Esteban Daudén, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
May 17, 2019
Cross-cultural selection and validation of instruments to assess patient-reported outcomes in children and adolescents with achondroplasia
Janika Bloemeke, Rachel Sommer, Stefanie Witt, et al.
Psoriasis (Auckland, N.Z.)
|
July 3, 2025
Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive Study
Ulrich Mrowietz, Rachel Sommer, Sascha Gerdes, et al.
Psoriasis (Auckland, N.Z.)
|
May 18, 2026
Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE Study
Ulrich Mrowietz, Rachel Sommer, Ziad Reguiai, et al.
Page
of 7